A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

NCT01827605 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

159

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Follicular Lymphoma

Interventions

OTHER: ZEVALIN
DRUG: BEAM

Sponsor

Fondazione Italiana Linfomi - ETS